NDA appoints Dr Panos Tsintis
June 22, 2010Sales and Marketing NDA, appointment, sales and marketing
European regulatory affairs consulting group NDA has appointed Dr Panos Tsintis medical advisor to NDA Regulatory Science in a move …
Dr Geoffrey Nichol joins Ikaria
June 22, 2010Research and Development Ikaria, appointment, research and development
US biotherapeutics company Ikaria has appointed Dr Geoffrey Nichol chief medical officer, with responsibility for its late-stage drug development activies. …
Working Life: Jo Ferdinando
June 22, 2010Manufacturing and Production, Research and Development Shire, Working Life, careers
How did you find your way into your most current role? After completing a BSc in Microbiology and Virology at …
Let’s avoid further stand-offs, says Witty
June 22, 2010Research and Development, Sales and Marketing EFPIA, Greece, industry, pricing
Pharma will need to find new ways of working with European governments in order to avoid further crises as witnessed …
Digital Pharma: Online trial safety reporting
June 21, 2010Research and Development FDA, MHRA, digital research, drug safety
From September all serious adverse events that occur during clinical trials in the UK will have to be reported electronically …
Bayer launches world’s first cannabis-derived prescription drug
June 21, 2010Sales and Marketing Bayer, GW Pharmaceuticals, Sativex
Bayer Healthcare has launched the world’s first cannabis-derived prescription drug in the UK. Sativex treats the spasticity symptoms of multiple …
GSK tops access to medicines ranking
June 21, 2010Sales and Marketing GlaxoSmithKline, developing world, medicines access
GlaxoSmithKline does the most of any pharma manufacturer to improve access to medicines needed in the developing world, according to …
Tasigna more effective than Glivec, says Novartis
June 21, 2010Research and Development, Sales and Marketing Glivec, Novartis, Tasigna, leukaemia
Novartis has gained US approval for Tasigna to be used as a front line treatment for chronic myeloid leukaemia. The …
Depomed pulls diabetes drug Glumetza
June 21, 2010Manufacturing and Production Depomed, Glumetza, manufacturing compliance
Another pharmaceutical manufacturer has been forced to recall products because of contamination caused by a chemical used to treat wooden …
AMRI buys Hyaluron to enter prefilled syringes market
June 21, 2010Manufacturing and Production AMRI, Hyaluron
Contract manufacturing organisation Albany Molecular Research Inc (AMRI) has added to its capabilities with the $27 million purchase of US …
NICE rejects Yondelis in ovarian cancer
June 21, 2010Sales and Marketing NICE, PharmaMar, Yondelis, ovarian cancer
New cancer treatment Yondelis has been rejected by NICE in a preliminary ruling on its use in relapsed ovarian cancer. …
Avastin will remain gold standard for lung cancer to 2018
June 20, 2010Decision Resources, NSCLC, Roche drug tipped to remain key to treatment, avastin
Industry analysts Decision Resources believes that Roche’s Avastin plus chemotherapy agents will remain as the gold standard for the treatment …
Digital Pharma: Byte-sized roundup
June 18, 2010Medical Communications, Research and Development FDA, Genzyme, NHS, Pfizer, digital pharma med coms, digital pharma research, social media
This week’s roundup includes an NHS football fitness game, Pfizer’s virtual exhibition booth, Amgen’s oncology site, reports FDA social media …
Fishawack acquires Alpha-Plus
June 18, 2010Medical Communications fishawack
Fishawack has acquired fellow medical communications agency Alpha-Plus as it continues its ‘buy and build’ expansion plan. This has recently …
Contract research news in brief
June 18, 2010Research and Development CRO, ClinStar, Covance, ICON, Parexel, Phlexglobal, Quintiles, chiltern, contract research
Good news abounds in the CRO sector at the moment, with a raft of business expansions, investments, and new contracts …
Prolia gets early thumbs up from NICE
June 18, 2010Sales and Marketing Amgen, NICE, Prolia
Amgen’s new treatment to prevent bone fractures caused by osteoporosis has been given preliminary approval from the UK’s cost effectiveness …
J&J expands recall of ‘musty’ products
June 18, 2010Manufacturing and Production Johnson & Johnson, manufacturing compliance
Johnson & Johnson’s manufacturing troubles continues to build with yet another recall announced this week, this time for additional lots …
MedImmune Ventures appoints Ron Laufer
June 18, 2010Research and Development AstraZeneca, MedImmune, appointment, research and development
Ron Laufer has joined MedImmune’s venture capital arm as senior managing director. The company, which is the worldwide biologics unit …
Bayer signs cancer stem cell research deal
June 18, 2010Research and Development Bayer Schering Pharma, Cancer, OncoMed, Stem cells
Bayer Schering Pharma has teamed up with a US oncology specialist to develop novel antibodies, protein therapeutics and small molecules …
Kemwell expands Swedish production unit
June 17, 2010Manufacturing and Production Kemwell, contract manufacturing
Indian contract manufacturer Kemwell has doubled production capacity at its facility in Sweden in order to help it serve customers …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
